Back to User profile » Dr Robert Wise
Papers published by Dr Robert Wise:
A Systematic Literature Review of the Humanistic, Economic, Sociodemographic, and Environmental Burden Associated with Severe COPD
Vlachaki I, Donhauser S, Wise RA, Chen Y, Madoni A, Scaffidi Argentina U, Mir JN, Quint JK
International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:2493-2523
Published Date: 17 July 2025
Disease Impact and Perception of Biologics in Adults with Type 2 Inflammation Respiratory Disease: International Survey Results
Tal-Singer R, Willard KS, Luttmann MA, Sprankle M, Reynolds J, Muerza Santos I, Jaffee H, Vichiendilokkul A, Jacomelli C, Novak Š, Gascon Moreno V, Wise RA
Patient Preference and Adherence 2025, 19:1159-1170
Published Date: 28 April 2025
Impact of Utilizing a Composite versus a Symptom-Only Validation Standard in the Development of the Asthma Impairment and Risk Questionnaire
Chipps BE, Zeiger RS, Beuther DA, Wise RA, McCann W, Reibman J, George M, Gilbert I, Eudicone JM, Coyne KS, Harding G, Murphy KR
Journal of Asthma and Allergy 2024, 17:751-756
Published Date: 7 August 2024
Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and Patient Perception of Disease Status, Health-Related Quality of Life, and Treatment Adherence
Reibman J, Chipps BE, Zeiger RS, Beuther DA, Wise RA, McCann W, Gilbert I, Eudicone JM, Gandhi HN, Harding G, Cutts K, Coyne KS, Murphy KR, George M
Journal of Asthma and Allergy 2023, 16:59-72
Published Date: 5 January 2023
Subgroup Analysis of a Randomized Trial of the Effects of Positive Messaging on Patient-Reported Outcomes with Asthma – Effect of Obesity
Mathews AM, Riley I, Henderson R, Holbrook JT, Lang JE, Dixon AE, Wise RA, Que LG
Journal of Asthma and Allergy 2022, 15:1743-1751
Published Date: 5 December 2022
Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial
Gabrio A, Gunsoy NB, Baio G, Martin A, Paly VF, Risebrough N, Halpin DMG, Singh D, Wise RA, Han MK, Martinez FJ, Criner GJ, Martin N, Lipson DA, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1633-1642
Published Date: 25 July 2022
The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD Trial
Wise RA, Chapman KR, Scirica BM, Daoud SZ, Lythgoe D, Garcia-Gil E
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:689-699
Published Date: 18 March 2021
A Novel Case-Finding Instrument for Chronic Obstructive Pulmonary Disease in Low- and Middle-Income Country Settings
Siddharthan T, Wosu AC, Pollard SL, Hossen S, Alupo P, Shade T, Kalyesubula R, Quaderi S, Wise RA, Hurst JR, Kirenga B, Checkley W
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2769-2777
Published Date: 3 November 2020
Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD
Calverley PMA, Anzueto AR, Dusser D, Mueller A, Metzdorf N, Wise RA
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1297-1308
Published Date: 23 April 2018
The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial
Patel NR, Cunoosamy DM, Fagerås M, Taib Z, Asimus S, Hegelund-Myrbäck T, Lundin S, Pardali K, Kurian N, Ersdal E, Kristensson C, Korsback K, Palmér R, Brown MN, Greenaway S, Siew L, Clarke GW, Rennard SI, Make BJ, Wise RA, Jansson P
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1009-1019
Published Date: 27 March 2018
Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR® trial
Wise RA, Calverley PMA, Carter K, Clerisme-Beaty E, Metzdorf N, Anzueto A
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:605-616
Published Date: 14 February 2018
Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
Calverley PMA, Tetzlaff K, Dusser D, Wise RA, Mueller A, Metzdorf N, Anzueto A
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3391-3405
Published Date: 29 November 2017
Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR® trial
Dusser D, Wise RA, Dahl R, Anzueto A, Carter K, Fowler A, Calverley PM
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:133-145
Published Date: 20 January 2016